Pfizer

Genelux names Mackey to board of directors

Tuesday, August 16, 2011 10:01 AM

Genelux, a privately held clinical stage biopharmaceutical company, has named Dr. Catherine J. Mackey to its board of directors.

More... »

CTTI report recommends risk-based monitoring

Monday, August 15, 2011 08:02 AM

Almost 90% of those conducting clinical trials within the commercial drug industry always perform on-site visits to their study sites. In contrast, about a third of academic, government or cooperative groups involved in research do. And yet, neither monitoring method is based on any evidence that it improves the quality of the data, as no such evidence yet exists.

More... »

Tornoe joins Exagen Diagnostics

Wednesday, August 10, 2011 11:09 AM

Exagen Diagnostics has named Eric Tornoe its president and chief operating officer.

More... »

Pfizer, UCSD sign potential $50 million research agreement

Monday, August 8, 2011 01:15 PM

In an innovative collaboration designed to speed the process of drug discovery, Pfizer and the University of California, San Diego health sciences report that UC San Diego has joined the ranks of other life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation (CTI).

More... »

Pfizer backs out of pact with Biotica

Thursday, August 4, 2011 11:12 AM

Pfizer has returned the rights to a rapamycin analogue program it has been running to explore the potential of diseases such as multiple sclerosis and lupus to the UK's Biotica Technology, according to PharmaTimes.

More... »

KKR acquires Pfizer’s Capsugel

Tuesday, August 2, 2011 11:01 AM

Pfizer has completed the sale of its Capsugel business to an affiliate of Kohlberg Kravis Roberts & Co. (KKR), following the receipt of required regulatory clearances, including in the U.S. and the European Union. Under the terms of the previously announced agreement, KKR acquired Capsugel for $2.375 billion in cash.

More... »

Critics raise concerns over research, incentives of European pediatric exclusivity regulations

Monday, August 1, 2011 08:00 AM

Regulations introduced four years ago in Europe to encourage research into medicines for children have lead to important therapeutic breakthroughs for pediatric patients.  Yet concerns also have been raised about how well the system works.

More... »

Insufficient advisory board members due to conflict-of-interest rules

Wednesday, July 27, 2011 01:19 PM

Conflict-of-interest rules restricting scientists with financial ties to drug and device- makers from advising U.S. regulators may loosen next year, said FDA Commissioner Margaret Hamburg, according to Bloomberg News.

More... »

Icon acquires Firecrest Clinical, adding portal technology to boost site quality while reducing errors and costs

Monday, July 25, 2011 08:02 AM

As large pharmaceutical companies scrutinize the pack of mid- and top-tier CROs to determine who wins the coveted strategic-partnership agreements, there’s a mad scramble among CROs to differentiate themselves from one another and stand out as efficient, high quality, exciting and deserving.

More... »

Pfizer to open research center in San Francisco’s Mission Bay

Friday, July 22, 2011 01:28 PM

Boosting Mission Bay's goal of becoming a hub for cutting-edge biotech, Pfizer has plans to establish a research center at the 303-acre former industrial site overlooking San Francisco Bay, according to the San Francisco Chronicle.

More... »